Categories AlphaGraphs, Earnings, Retail

Key metrics from Macy’s (M) Q3 2025 earnings results

Macy’s, Inc. (NYSE: M) reported its third quarter 2025 earnings results today.

Net sales of $4.71 billion dipped slightly from the same period a year ago.

Comparable sales were up 2.5% on an owned basis and up 3.2% on an owned-plus-licensed-plus-marketplace (O+L+M) basis.  

Net income was $11 million, or $0.04 per share, compared to $28 million, or $0.10 per share, last year. Adjusted EPS rose to $0.09 from $0.04 last year.

Revenue and earnings beat expectations.

For fiscal year 2025, net sales are expected to be $21.47-21.62 billion. Comparable owned-plus-licensed-plus-marketplace sales are expected to be flat to up 0.5% versus FY2024. Adjusted EPS is expected to be $2.00-2.20.

Despite the earnings beat, the stock fell over 5% in premarket hours on Wednesday.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with renal diseases. In an email interview with AlphaStreet, CEO Dr.

Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top